Evidence map›Paper›PMID 40874124›Full record

ArticleFrontiers in neurology2025

Nomogram based on pan-immune-inflammation value to predict short-term prognosis in spontaneous intracerebral hemorrhage.

Shuai Wang, Wei Zhang, Jingjing Li, Xinxin Yang, Yuqiao Wang

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuai Wang *Department of Neurology, The First Clinical Medical College of Xuzhou Medical University, Xuzhou, China.
Wei Zhang *Department of Neurology, Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
Jingjing LiDepartment of Neurology, The First Clinical Medical College of Xuzhou Medical University, Xuzhou, China.
Xinxin YangDepartment of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yuqiao WangDepartment of Neurology, The First Clinical Medical College of Xuzhou Medical University, Xuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The aim of this study was to investigate the impact of the Pan-Immune-Inflammation Value (PIV) on the prognosis of spontaneous intracerebral hemorrhage (ICH) and to develop and validate a nomogram for identifying patients with a poor prognosis following ICH. Methods: We retrospectively collected the clinical data of 742 patients with ICH admitted to the Affiliated Hospital of Xuzhou Medical University from September 2018 to March 2024. A modified Rankin Scale score > 3 at 90 days after discharge was defined as a poor short-term prognosis. The enrolled patients were randomly assigned to a training cohort and a validation cohort in a 7:3 ratio. In the training cohort, risk factors associated with poor short-term prognosis were identified through univariate and multivariate logistic regression analyses. Based on these risk factors, a nomogram was developed and validated. Results: Of the 742 ICH patients included in this study, 519 were assigned to the training cohort and 223 to the validation cohort. Multivariate logistic regression analysis identified several risk factors for poor prognosis of ICH: brainstem hemorrhage (OR = 3.17, 95% CI = 1.80-5.59, Conclusion: A high PIV level, large bleeding volume, and low GCS score are significant risk factors for poor prognosis in patients with ICH. The nomogram based on these factors demonstrates robust predictive performance.

Indexed as

clinical studyintracerebral hemorrhagenomogrampan-immune-inflammation valueprognosis

Identifiers

PMID40874124
PMCPMC12378056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.